Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Prognostic and predictive markers in glioma and other neuroepithelial tumors.

Rivera AL, Pelloski CE, Sulman E, Aldape K.

Curr Probl Cancer. 2008 May-Jun;32(3):97-123. doi: 10.1016/j.currproblcancer.2008.02.003. Review. No abstract available.

PMID:
18501774
2.

Global histone modification patterns as prognostic markers to classify glioma patients.

Liu BL, Cheng JX, Zhang X, Wang R, Zhang W, Lin H, Xiao X, Cai S, Chen XY, Cheng H.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2888-96. doi: 10.1158/1055-9965.EPI-10-0454.

3.

Molecular markers of glioma: an update on recent progress and perspectives.

Gupta K, Salunke P.

J Cancer Res Clin Oncol. 2012 Dec;138(12):1971-81. doi: 10.1007/s00432-012-1323-y. Review.

PMID:
23052697
4.

Notch1 identified as a prognostic factor for glioma patients.

Engh JA.

Neurosurgery. 2011 Jun;68(6):N22-3. doi: 10.1227/01.neu.0000398213.42865.91. Review. No abstract available.

PMID:
21778948
5.

Correlative studies in neuro-oncology trials: should they influence treatment?

Hegi ME, Stupp R.

Curr Oncol Rep. 2006 Jan;8(1):54-7. Review.

PMID:
16464404
6.

New developments and controversies in the neuropathology of malignant gliomas.

Wiestler OD, Schmidt MC, von Deimling A, Reifenberger G, Deckert-Schl├╝ter M, Radner H, Pietsch T.

Front Radiat Ther Oncol. 1999;33:123-38. Review. No abstract available.

PMID:
10549483
7.

An introduction to molecular analysis and characterization of gliomas.

Ausman JI.

Surg Neurol. 2005 Oct;64(4):285. No abstract available.

PMID:
16181992
8.

Glioma diagnosis: immunohistochemistry and beyond.

Dunbar E, Yachnis AT.

Adv Anat Pathol. 2010 May;17(3):187-201. doi: 10.1097/PAP.0b013e3181d98cd9. Review.

PMID:
20418673
9.

Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.

Shinohara C, Muragaki Y, Maruyama T, Shimizu S, Tanaka M, Kubota Y, Oikawa M, Nakamura R, Iseki H, Kubo O, Takakura K, Hori T.

Jpn J Clin Oncol. 2008 Nov;38(11):730-3. doi: 10.1093/jjco/hyn099.

10.

Diagnosis of malignant glioma: role of neuropathology.

Brat DJ, Prayson RA, Ryken TC, Olson JJ.

J Neurooncol. 2008 Sep;89(3):287-311. doi: 10.1007/s11060-008-9618-1. No abstract available.

PMID:
18712282
11.

Risk assignment in childhood brain tumors: the emerging role of molecular and biologic classification.

Pollack IF, Biegel J, Yates A, Hamilton R, Finkelstein S.

Curr Oncol Rep. 2002 Mar;4(2):114-22. Review.

PMID:
11822983
12.

Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.

Wen PY, Reardon DA.

Nat Rev Neurol. 2016 Feb;12(2):69-70. doi: 10.1038/nrneurol.2015.242. Review. No abstract available.

PMID:
26782337
13.

MicroRNAs might be promising biomarkers of human gliomas.

Wang H, Yuan X, Zhou Z, Hu J, Zhang T, Hu S, Luo J, Li X.

Asian Pac J Cancer Prev. 2011;12(4):833-5. Review.

14.

[Molecular diagnostic testing in gliomas].

Hasselblatt M.

Pathologe. 2008 Nov;29(6):422-7. doi: 10.1007/s00292-008-1060-9. German.

PMID:
18779965
15.

Clinical implications of Girdin protein expression in glioma.

Zhao L, Ma S, Liu Q, Liang P.

ScientificWorldJournal. 2013 Oct 27;2013:986073. doi: 10.1155/2013/986073.

16.

[Standards, guidelines, and options in the treatment of glial tumors of the brain in adults].

Konovalov AN, Potapov AA, Loshakov VA, Oliushin VE, Kornienko VN, Iartsev VV, Pronin IN, Korshunov AG, Golanov AV, Kobiakov GL, Mariashev SA, Zelenkov PA.

Zh Vopr Neirokhir Im N N Burdenko. 2006 Apr-Jun;(2):3-11. Russian. No abstract available.

PMID:
16827422
17.

Brain tumor stem cells.

Sulman E, Aldape K, Colman H.

Curr Probl Cancer. 2008 May-Jun;32(3):124-42. doi: 10.1016/j.currproblcancer.2008.02.004. Review. No abstract available.

PMID:
18501775
18.

Cystic glioma of the cerebral hemispheres, with long survival. A clinical-pathological study of 7 cases.

Drapkin AJ, Behar AJ, Beller AJ.

Acta Neuropathol. 1973 Dec 3;26(4):353-6. No abstract available.

PMID:
4774321
19.

Biomarkers and cancer stem cells in primary brain tumors. Foreword.

Bogler O, Sawaya R.

Curr Probl Cancer. 2008 May-Jun;32(3):95-6. doi: 10.1016/j.currproblcancer.2008.02.002. No abstract available.

PMID:
18501773
20.

Immunohistochemical detection of class III beta-tubulin in primary brain tumours: variable expression in most tumour types limits utility as a differential diagnostic marker.

Laggner U, Pipp I, Budka H, Hainfellner JA, Preusser M.

Histopathology. 2007 Jun;50(7):949-52. No abstract available.

PMID:
17543088
Items per page

Supplemental Content

Support Center